LONRF1 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 3.701600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
3.043600E-01
Normal-vs-Stage2
3.689400E-01
Normal-vs-Stage3
2.525200E-01
Normal-vs-Stage4
9.066400E-01
Stage1-vs-Stage2
1.509630E-01
Stage1-vs-Stage3
3.154600E-01
Stage1-vs-Stage4
2.973600E-01
Stage2-vs-Stage3
2.236000E-01
Stage2-vs-Stage4
3.797000E-01
Stage3-vs-Stage4
2.326200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
3.773800E-01
Normal-vs-AfricanAmerican
1.719180E-01
Normal-vs-Asian
2.532800E-01
Caucasian-vs-AfricanAmerican
8.587000E-01
Caucasian-vs-Asian
5.598400E-02
AfricanAmerican-vs-Asian
1.675430E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
3.528600E-01
Normal-vs-Female
3.953600E-01
Male-vs-Female
2.975200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
2.300400E-01
Normal-vs-Age(41-60Yrs)
4.400800E-01
Normal-vs-Age(61-80Yrs)
3.519000E-01
Normal-vs-Age(81-100Yrs)
4.698100E-02
Age(21-40Yrs)-vs-Age(41-60Yrs)
2.474000E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
6.134800E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
9.356800E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
6.071800E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
5.640100E-02
Age(61-80Yrs)-vs-Age(81-100Yrs)
4.178400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
3.052200E-01
Normal-vs-Daily Drinker
3.374600E-01
Normal-vs-Weekly Drinker
3.199000E-01
Normal-vs-Occasional Drinker
3.780800E-01
Normal-vs-Social Drinker
1.534220E-01
Non Drinker-vs-Daily Drinker
5.960200E-01
Non Drinker-vs-Weekly Drinker
2.663400E-01
Non Drinker-vs-Occasional Drinker
2.176200E-01
Non Drinker-vs-Social Drinker
7.883600E-02
Daily Drinker-vs-Weekly Drinker
4.126800E-01
Daily Drinker-vs-Occasional Drinker
5.602200E-01
Daily Drinker-vs-Social Drinker
2.617600E-01
Weekly Drinker-vs-Occasional Drinker
6.109600E-01
Weekly Drinker-vs-Social Drinker
9.511400E-01
Occasional Drinker-vs-Social Drinker
4.940000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
6.164000E-02
Normal-vs-Grade 2
1.677720E-02
Normal-vs-Grade 3
2.718400E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
1.467780E-01
Grade 1-vs-Grade 3
7.963800E-01
Grade 1-vs-Grade 4
6.164000E-02
Grade 2-vs-Grade 3
1.535630E-01
Grade 2-vs-Grade 4
1.677720E-02
Grade 3-vs-Grade 4
2.718400E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
3.567000E-01
Normal-vs-NonDiabetic
3.524000E-01
Diabetic-vs-NonDiabetic
9.678800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
3.308600E-01
Normal-vs-NoPancreatitis
3.572200E-01
Pancreatitis-vs-NoPancreatitis
6.565800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
3.456600E-01
Normal-vs-N1
3.834600E-01
N0-vs-N1
3.319600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
1.956760E-01
Normal-vs-TP53-NonMutant
4.848300E-02
TP53-Mutant-vs-TP53-NonMutant
3.348000E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
